Stockreport

Werewolf Therapeutics to Present at H. C. Wainwright Global Investment Conference

Werewolf Therapeutics, Inc.  (HOWL) 
PDF CAMBRIDGE, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of [Read more]